Rudi Kundini, Pamoja Kundini: Phase I

Summary

This protocol describes a 2-arm cluster, randomized controlled trial designed to test the effectiveness of a conditional cash transfer on viral suppression at 6 months among people living with HIV infection (PLHIV) in Tanzania who have disengaged from HIV care. Randomization will take place at the clinic level (HIV primary care clinics). The comparison group receives standard of care standard of care HIV tracing services according to Tanzania's National Guidelines for the Management of HIV and the Ministry of Health to locate potential participants, including home based care (HBC) tracing of PLHIV who have disengaged from primary care, the provision of counseling to return to HIV care, and the offer to schedule an HIV primary care appointment on the spot. Eligible adult PLHIV disengaged from HIV care and living in an intervention facility catchment area will receive the same standard of care HIV tracing and clinical services as control participants, plus the opportunity to receive a one-time cash transfer incentive, conditional upon confirmed completion of a clinical visit if within 90 days of study enrollment. The primary endpoint is viral suppression (\<1000 copies/ml) at 6 months after study enrollment.

Conditions

• HIV (Human Immunodeficiency Virus)

Interventions

BEHAVIORAL

Conditional Cash Transfer

The intervention is a one-time cash transfer of 22,500 Tanzanian Shillings (\~$10), with half (11,250 TSH) delivered upon enrollment in the study and half delivered after confirmation of the completion of a clinical visit if within 90 days of study enrollment.

Sponsors & Collaborators

• Health for a Prosperous Nation

  collaborator OTHER

• Rasello

  collaborator INDUSTRY

• Management and Development for Health

  collaborator UNKNOWN

• Ministry of Health, Tanzania

  collaborator OTHER_GOV

• National Institute of Mental Health (NIMH)

  collaborator NIH

• University of California, Berkeley

  lead OTHER

Principal Investigators

• Jingshen Wang, PhD · University of California, Berkeley

Study Design

Allocation

RANDOMIZED

Purpose

OTHER

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-07-13

Primary Completion

2024-07-12

Completion

2024-12-03

Countries

• Tanzania

Study Locations